About NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.

Top 100 in Biopharma
Top 100 in Pharmaceutical in United States
Top 100 in Biopharma in United States
Company Highlights
Year Founded

2017

icon-altEmployees

7

Location (HQ)

USA

Since Last Funding

3 months

Monthly Website Visitors

1.1K

icon-altTotal Investment Amt

$3.6M

Last Funding Round

Series Unknown

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical

Biopharma